Nutex Health Inc. (NASDAQ:NUTX - Get Free Report)'s share price gapped up before the market opened on Thursday . The stock had previously closed at $122.29, but opened at $127.50. Nutex Health shares last traded at $118.99, with a volume of 93,844 shares.
Analyst Upgrades and Downgrades
Several analysts have commented on NUTX shares. Wall Street Zen lowered shares of Nutex Health from a "strong-buy" rating to a "buy" rating in a report on Thursday, May 22nd. Maxim Group raised their price objective on shares of Nutex Health from $100.00 to $225.00 and gave the stock a "buy" rating in a report on Tuesday, May 20th. Finally, Benchmark raised their price objective on shares of Nutex Health from $150.00 to $300.00 and gave the stock a "buy" rating in a report on Thursday, May 15th.
Read Our Latest Report on Nutex Health
Nutex Health Stock Down 2.4%
The company has a quick ratio of 2.26, a current ratio of 2.27 and a debt-to-equity ratio of 1.02. The company's fifty day simple moving average is $134.51 and its 200 day simple moving average is $87.17. The firm has a market capitalization of $663.86 million, a PE ratio of 10.04 and a beta of -0.04.
Nutex Health (NASDAQ:NUTX - Get Free Report) last issued its quarterly earnings data on Tuesday, May 13th. The company reported $2.56 EPS for the quarter, topping the consensus estimate of ($0.15) by $2.71. Nutex Health had a net margin of 10.76% and a return on equity of 42.08%. The business had revenue of $211.79 million during the quarter, compared to analyst estimates of $81.09 million.
Insider Buying and Selling
In other Nutex Health news, CFO Jon Christian Bates purchased 1,000 shares of the company's stock in a transaction dated Tuesday, April 8th. The shares were acquired at an average price of $81.81 per share, for a total transaction of $81,810.00. Following the purchase, the chief financial officer directly owned 4,888 shares of the company's stock, valued at $399,887.28. The trade was a 25.72% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 36.92% of the company's stock.
Institutional Trading of Nutex Health
A number of large investors have recently made changes to their positions in NUTX. Essex Investment Management Co. LLC grew its holdings in Nutex Health by 45.4% during the 4th quarter. Essex Investment Management Co. LLC now owns 105,809 shares of the company's stock valued at $3,353,000 after purchasing an additional 33,024 shares during the last quarter. American Century Companies Inc. purchased a new stake in shares of Nutex Health in the 4th quarter worth approximately $1,362,000. Geode Capital Management LLC lifted its position in shares of Nutex Health by 12.6% in the 4th quarter. Geode Capital Management LLC now owns 34,125 shares of the company's stock worth $1,082,000 after purchasing an additional 3,826 shares during the period. World Investment Advisors purchased a new stake in shares of Nutex Health in the 4th quarter worth approximately $217,000. Finally, Russell Investments Group Ltd. purchased a new stake in shares of Nutex Health in the 4th quarter worth approximately $672,000. 5.32% of the stock is currently owned by institutional investors.
Nutex Health Company Profile
(
Get Free Report)
Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.
Featured Articles
Before you consider Nutex Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nutex Health wasn't on the list.
While Nutex Health currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.